Inhibitory effects of relaxin on cardiac fibroblast-to-myofibroblast transition: An electrophysiological study

Experimental Physiology

Volumn 100, Issue 6, 2015, Pages 652-666

  Squecco, Roberta ^a   Sassoli, Chiara ^a   Garella, Rachele ^a   Chellini, Flaminia ^a   Idrizaj, Eglantina ^a   Nistri, Silvia ^a   Formigli, Lucia ^a   Bani, Daniele ^a   Francini, Fabio ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIFIBROTIC AGENT; CALCIUM ION; RELAXIN; TRANSFORMING GROWTH FACTOR BETA1; VOLTAGE GATED CALCIUM CHANNEL; BIOLOGICAL MARKER; DELAYED RECTIFIER POTASSIUM CHANNEL; INWARDLY RECTIFYING POTASSIUM CHANNEL; POTASSIUM; RECOMBINANT PROTEIN; RLN2 PROTEIN, HUMAN; TGFB1 PROTEIN, HUMAN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CALCIUM CURRENT; CELL DIFFERENTIATION; CELL MEMBRANE; CONTROLLED STUDY; DISEASE MARKER; DRUG EFFECT; ELECTROPHYSIOLOGY; FIBROBLAST; HEART MUSCLE FIBROSIS; ION CURRENT; MEMBRANE POTENTIAL; MOUSE; MYOFIBROBLAST; NONHUMAN; POTASSIUM CURRENT; STROMA CELL; WHOLE CELL PATCH CLAMP; 3T3 CELL LINE; ANIMAL; DRUG EFFECTS; FIBROSIS; HUMAN; METABOLISM; PATHOLOGY; PHENOTYPE;

ANIMALS; BIOMARKERS; CELL DIFFERENTIATION; CELL MEMBRANE; DELAYED RECTIFIER POTASSIUM CHANNELS; FIBROBLASTS; FIBROSIS; HUMANS; MEMBRANE POTENTIALS; MICE; MYOFIBROBLASTS; NIH 3T3 CELLS; PHENOTYPE; POTASSIUM; POTASSIUM CHANNELS, INWARDLY RECTIFYING; RECOMBINANT PROTEINS; RELAXIN; TRANSFORMING GROWTH FACTOR BETA1;

EID: 84930573098     PISSN: 09580670     EISSN: 1469445X     Source Type: Journal    
DOI: 10.1113/EP085178     Document Type: Article

References (37)

1. Askar SF, Bingen BO, Swildens J, Ypey DL, vander Laarse A, Atsma DE, Zeppenfeld K, Schalij MJ, deVries AA & Pijnappels DA (2012). Connexin43 silencing in myofibroblasts prevents arrhythmias in myocardial cultures: role of maximal diastolic potential. Cardiovasc Res 93, 434-444.
2. Baccari MC & Bani D (2008). Relaxin and nitric oxide signalling. Curr Protein Pept Sci 9, 638-645.
3. Baglioni S, Cantini G, Poli G, Francalanci M, Squecco R, Di Franco A, Borgogni E, Frontera S, Nesi G, Liotta F, Lucchese M, Perigli G, Francini F, Forti G, Serio M & Luconi M (2012). Functional differences in visceral and subcutaneous fat pads originate from differences in the adipose stem cell. PLoS ONE 7, e36569.
4. Baglioni S, Francalanci M, Squecco R, Lombardi A, Cantini G, Angeli R, Gelmini S, Guasti D, Benvenuti S, Annunziato F, Bani D, Liotta F, Francini F, Perigli G, Serio M & Luconi M (2009). Characterization of human adult stem-cell populations isolated from visceral and subcutaneous adipose tissue. FASEB J 23, 3494-3505.
5. Bani D & Nistri S (2014). New insights into the morphogenic role of stromal cells and their relevance for regenerative medicine. Lessons from the heart. J Cell Mol Med 183, 363-370.
6. Bataller R, Gasull X, Ginès P, Hellemans K, Görbig MN, Nicolás JM, Sancho-Bru P, DeLas Heras D, Gual A, Geerts A, Arroyo V & Rodés J (2001). In vitro and in vivo activation of rat hepatic stellate cells results in de novo expression of L-type voltage-operated calcium channels. Hepatology 33, 956-962.
7. Benvenuti S, Saccardi R, Luciani P, Urbani S, Deledda C, Cellai I, Francini F, Squecco R, Rosati F, Danza G, Gelmini S, Greve I, Rossi M, Maggi R, Serio M & Peri A (2006). Neuronal differentiation of human mesenchymal stem cells: changes in the expression of the Alzheimer's disease related gene seladin-1. Exp Cell Res 312, 2592-2604.
8. Camelliti P, Green CR, LeGrice I & Kohl P (2004). Fibroblast network in rabbit sinoatrial node. Circ Res 94, 828-835.
9. v1.5 sodium channels in human atrial fibroblasts differentiated into myofibroblasts. J Physiol 590, 4307-4319.
10. Cheng CJ, Sung CC, Huang CL & Lin SH (2015). Inward-rectifying potassium channelopathies: new insights into disorders of sodium and potassium homeostasis. Pediatr Nephrol 30, 373-383.
11. Chilton L, Giles WR & Smith GL (2007). Evidence of intercellular coupling between co-cultured adult rabbit ventricular myocytes and myofibroblasts. J Physiol 583, 225-236.
12. + currents regulate the resting membrane potential, proliferation, and contractile responses in ventricular fibroblasts and myofibroblasts. Am J Physiol Heart Circ Physiol 288, H2931-H2939.
13. Formigli L, Francini F, Nistri S, Margheri M, Luciani G, Naro F, Silvertown JD, Orlandini SZ, Meacci E & Bani D (2009). Skeletal myoblasts overexpressing relaxin improve differentiation and communication of primary murine cardiomyocyte cell cultures. J Mol Cell Cardiol 47, 335-345.
14. Formigli L, Francini F, Tani A, Squecco R, Nosi D, Polidori L, Nistri S, Chiappini L, Cesati V, Pacini A, Perna AM, Orlandini GE, Zecchi-Orlandini S, Bani D (2005a). Morphofunctional integration between skeletal myoblasts and adult cardiomyocytes in coculture is favored by direct cell-cell contacts and relaxin treatment. Am J Physiol Cell Physiol 288, C795-C804.
15. Formigli L, Meacci E, Sassoli C, Chellini F, Giannini R, Quercioli F, Tiribilli B, Squecco R, Bruni P, Francini F & Zecchi-Orlandini S (2005b). Sphingosine 1-phosphate induces cytoskeletal reorganization in C2C12 myoblasts: physiological relevance for stress fibres in the modulation of ion current through stretch-activated channels. J Cell Sci 118, 1161-1171.
16. Gabbiani G (2003). The myofibroblast in wound healing and fibrocontractive diseases. J Pathol 200, 500-503.
17. Goldsmith EC, Hoffman A, Morales MO, Potts JD, Price RL, McFadden A, Rice M & Borg TK (2004). Organization of fibroblasts in the heart. Dev Dyn 230, 787-794.
18. Huang X, Gai Y, Yang N, Lu B, Samuel CS, Thannickal VJ & Zhou Y (2011). Relaxin regulates myofibroblast contractility and protects against lung fibrosis. Am J Pathol 179, 2751-2765.
19. Hinz B, Phan SH, Thannickal VJ, Prunotto M, Desmoulière A, Varga J, DeWever O, Mareel M & Gabbiani G (2012). Recent developments in myofibroblast biology: paradigms for connective tissue remodeling. Am J Pathol 180, 1340-1355.
20. Kohl P, Camelliti P, Burton FL & Smith GL (2005). Electrical coupling of fibroblasts and myocytes: relevance for cardiac propagation. J Electrocardiol 38(4 Suppl), 45-50.
21. McDowell KS, Arevalo HJ, Maleckar MM & Trayanova NA (2011). Susceptibility to arhythmia in the infarcted heart depends on myofibroblast density. Biophys J 101, 1307-1315.
22. Mewton N, Liu CY, Croisille P, Bluemke D & Lima JA (2011). Assessment of myocardial fibrosis with cardiovascular magnetic resonance. J Am Coll Cardiol 57, 891-903.
23. Mookerjee I, Hewitson TD, Halls ML, Summers RJ, Mathai ML, Bathgate RA, Tregear GW & Samuel CS (2009). Relaxin inhibits renal myofibroblast differentiation via RXFP1, the nitric oxide pathway, and Smad2. FASEB J 23, 1219-1229.
24. Nguyen TP, Xie Y, Garfinkel A, Qu Z & Weiss JN (2012). Arrhythmogenic consequences of myofibroblast-myocyte coupling. Cardiovasc Res 93, 242-251.
25. Nistri S, Pini A, Sassoli C, Squecco R, Francini F, Formigli L & Bani D (2012). Relaxin promotes growth and maturation of mouse neonatal cardiomyocytes in vitro: clues for cardiac regeneration. J Cell Mol Med 16, 507-519.
26. Pappone PA, Lee SC (1996). Purinergic receptor stimulation increase membrane trafficking in brown adipocytes. J Gen Physiol 108, 393-404.
27. Samuel CS, Cendrawan S, Gao XM, Ming Z, Zhao C, Kiriazis H, Xu Q, Tregear GW, Bathgate RA & Du XJ (2011). Relaxin remodels fibrotic healing following myocardial infarction. Lab Invest 91, 675-690.
28. Samuel CS, Unemori EN, Mookerjee I, Bathgate RA, Layfield SL, Mak J, Tregear GW & Du XJ (2004). Relaxin modulates cardiac fibroblast proliferation, differentiation, and collagen production and reverses cardiac fibrosis in vivo. Endocrinology 145, 4125-4133.
29. Sassoli C, Chellini F, Pini A, Tani A, Nistri S, Nosi D, Zecchi-Orlandini S, Bani D & Formigli L (2013). Relaxin prevents cardiac fibroblast-myofibroblast transition via notch-1-mediated inhibition of TGF-β/Smad3 signaling. PLoS ONE 8, e63896.
30. Ca) channels. J Physiol 590, 5937-5947.
31. Tomasek JJ, Gabbiani G, Hibnz B, Chaponnier C & Brown RA (2002). Myofibroblasts and mechano-regulation of connective tissue remodelling. Nat Rev Mol Cell Biol 3, 349-363.
32. Vasquez C, Benamer N & Morley GE (2011). The cardiac fibroblast: functional and electrophysiological considerations in healthy and diseased hearts. J Cardiovasc Pharmacol 57, 380-388.
33. - current activity and fibroblast-to-myofibroblast differentiation. Am J Physiol Cell Physiol 294, C535-C542.
34. Yue L, Xie J & Nattel S (2011). Molecular determinants of cardiac fibroblast electrical function and therapeutic implications for atrial fibrillation. Cardiovasc Res 89, 744-753.
35. Zhang K, Flanders KC & Phan SH (1998). Cellular localization of transforming growth factor expression in bleomycin-induced pulmonary fibrosis. Am J Pathol 147, 352-361.
36. Zhang K, Gharaee-Kermani M, Jones ML, Warren JS & Phan SH (1994). Lung monocyte chemoattractant protein-1 gene expression in bleomycin-induced pulmonary fibrosis. J Immunol 153, 4733-4741.
37. + channels: novel players in fibroblast-to-myofibroblast transition with a potential role in atrial arrhythmogenesis? J Physiol 590, 4975.